학술논문
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial
Document Type
Article
Author
Goldschmidt, H.; Mai, E.K.; Bertsch, U.; Merz, M.; Hügle-Dörr, B.; Giesen, N.; Hose, D.; Seckinger, A.; Huhn, S.; Hillengass, J.; Raab, M.S.; Dürig, J.; Scheid, C.; Weisel, K.C.; Kunz, C.; Hielscher, T.; Tichy, D.; Munder, M.; Lindemann, H.-W.; Luntz, S.; Rabold, B.; Jauch, A.; Elmaagacli, A.; Fuhrmann, S.; Brossart, P.; Goerner, M.; Bernhard, H.; Hoffmann, M.; Blau, I.W.; Hänel, M.; Salwender, H.J.
Source
In: Leukemia . (Leukemia, 1 July 2020, 34(7):1853-1865)
Subject
Language
English
ISSN
14765551
08876924
08876924